anti-transglutaminase

Ancora biopsia? Forse no!

S. De Virgilis

2005/7 — pag. 437-455

Recently, serum of celiac patients affected by autoimmune hepatitis revealed autoantibodies directed against actin filaments (AAA). The preliminary results regarding AAA showed a strong correlation between AAA antibody titre and the severity of int...

Prevalenza di malattia celiaca in bambini con deficit totale di IgA non identificati dagli IgG e riconosciuta dal test ELISA per anti-htTG

A. Lenhardt, A. Plebani, A Insalaco, A. Rovelli, A. Tommasini, V. Villanacci, A. Ventura

2001/9 — pag. 623-625

The serum of 134 subjects with IgA deficiency was studied by carrying out an ELISA IgG test for anti-htTG antibodies and an AGA IgG test. The ELISA test was positive in 16 cases out of 134: AGA IgG test was positive in 22 cases out of 134. Out of ...

Importanza del testing nella malattia celiaca

P. Matti, S. Senter

2001/5 — pag. 323-324

Inibizione dell’apoptosi da parte degli anticorpi monoclonali umani anti-transglutaminasi

A. Tommasini, M. Soban, I. Berti, C. Trevisiol, E. Panfili, D. Santon, Lenhardt, V. Baldas, E. Fragonas

2000/6 — pag. 391-393

The celiac disease is characterized by the production of tTG (antitransglutaminase) antibodies. These antibodies could only be a marker of the disease, or, which is more likely, could be involved in the pathogenesis of intestinal lesions (inhibiti...

Lo screening della celiachia: le ragioni del medico dell’adulto

B. Ciacci

2000/1 — pag. 26-30

The clinical features of coeliac disease diagnosed in a series of 517 adult patients are described. The most frequent signs and symptoms are iron deficiency anemia, which is particularly prevalent among women, bone demineralization, diarrohea and m...

Celiachia: screening sì, screening no. O cosa?

A. Ventura, A. Tommasini

2000/1 — pag. 7-9